S. Fujinaga

发表

Is it possible to avoid unnecessary voiding cystourethrography by performing acute Technetium-99m dimercaptosuccinic acid scintigraphy and renal ultrasound scanning after first febrile urinary tract infection in children?

Toshiaki Shimizu, Y. Inoue, D. Hirano, 2011 .

Acute kidney injury following plastic bronchitis associated with influenza B virus in a child with nephrotic syndrome

S. Fujinaga, Taichi Hara, 2015, Indian Pediatrics.

A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2007, Pediatric Nephrology.

Low-dose pulse methylprednisolone followed by short-term combination therapy and tonsillectomy for childhood IgA nephropathy

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2010, Pediatric Nephrology.

Induction therapy with rituximab for lupus nephritis due to prolidase deficiency.

K. Imai, Takuma Ohnishi, Kimitoshi Nakamura, 2020, Rheumatology.

Clinical features of macrophage activation syndrome as the onset manifestation of juvenile systemic lupus erythematosus

A. Nakazawa, S. Fujinaga, Satoshi Sato, 2019, Rheumatology advances in practice.

Efficacy and safety of darbepoetin alfa for anemia in children with chronic kidney disease: a multicenter prospective study in Japan

S. Ito, M. Hattori, T. Akizawa, 2013, Clinical and Experimental Nephrology.

Darbepoetin alfa for the treatment of anemia in children undergoing peritoneal dialysis: a multicenter prospective study in Japan

S. Ito, M. Hattori, Takuhito Nagai, 2013, Clinical and Experimental Nephrology.

Induction therapy with low-dose intravenous cyclophosphamide, oral mizoribine, and steroids for severe lupus nephritis in children

K. Kaneko, Y. Yamashiro, S. Akashi, 2005, Pediatric Nephrology.

Clinical, pathological, and genetic characteristics of cases with asymptomatic proteinuria not manifesting nephrotic syndrome at onset: a single-center retrospective study

K. Nozu, Yoshitaka Watanabe, S. Fujinaga, 2022, Clinical and Experimental Nephrology.

Initial treatment with pulse methylprednisolone followed by short-term prednisolone and tonsillectomy for childhood IgA nephropathy

D. Hirano, S. Fujinaga, A. Yamada, 2018, Clinical and Experimental Nephrology.

Yokukansan: A Treatment Option for Nocturnal Enuresis in Children by Improving Sleep Quality

Toshiaki Shimizu, S. Fujinaga, Y. Ohtomo, 2014 .

Traditional Japanese medicine, Yokukansan, for the treatment of nocturnal enuresis in children

Toshiaki Shimizu, S. Fujinaga, Y. Ohtomo, 2013, Pediatrics international : official journal of the Japan Pediatric Society.

Hydrogen-rich water reduced oxidative stress and renal fibrosis in rats with unilateral ureteral obstruction

Toshiaki Shimizu, D. Hirano, A. Endo, 2021, Pediatric Research.

Thin basement membrane nephropathy associated with minimal change disease in a 15-year-old boy

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2006, Pediatric Nephrology.

Does Low-Dose Intravenous Methylprednisolone Pulse Therapy Produce Unacceptable Adverse Effects in Children? *

H. Ida, D. Hirano, A. Endo, 2013 .

Evaluation of kidney dysfunction and angiotensinogen as an early novel biomarker of intrauterine growth restricted offspring rats

Toshiaki Shimizu, D. Hirano, A. Endo, 2015, Pediatric Research.

The synergistic effect of mizoribine and a direct renin inhibitor, aliskiren, on unilateral ureteral obstruction induced renal fibrosis in rats.

Toshiaki Shimizu, D. Hirano, A. Endo, 2014, The Journal of urology.

Protective Effects of Hydrogen-rich Water Intake on Renal Injury in Neonatal Rats with High Oxygen Loading

A. Endo, N. Nishizaki, S. Fujinaga, 2022, Juntendo Medical Journal.

Impaired nephrogenesis in neonatal rats with oxygen‐induced retinopathy

Toshiaki Shimizu, D. Hirano, A. Endo, 2017, Pediatrics international : official journal of the Japan Pediatric Society.

Long-term outcomes after early treatment with rituximab for Japanese children with cyclosporine- and steroid-resistant nephrotic syndrome

Yoshitaka Watanabe, S. Fujinaga, T. Nishino, 2018, Pediatric Nephrology.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: medical therapy

K. Nakanishi, Takuhito Nagai, K. Iijima, 2014, Clinical and Experimental Nephrology.

Positive effects of single-daily high-dose mizoribine therapy after cyclophosphamide in young children with steroid-dependent nephrotic syndrome

Toshiaki Shimizu, D. Hirano, S. Fujinaga, 2018, Clinical and Experimental Nephrology.

Uncertainty in management of childhood-onset idiopathic nephrotic syndrome: is the long-term prognosis really favorable?

Toshiaki Shimizu, A. Endo, S. Fujinaga, 2013, Pediatric Nephrology.

Suplatast tosilate dimethylsulfonium treatment for steroid‐dependent nephrotic syndrome

M. Hattori, S. Fujinaga, Y. Ohtomo, 2005, Pediatrics international : official journal of the Japan Pediatric Society.

Th1/Th2 balance in childhood idiopathic nephrotic syndrome.

K. Kaneko, Y. Yamashiro, S. Fujinaga, 2002, Clinical nephrology.

Single infusion of rituximab for persistent steroid-dependent minimal-change nephrotic syndrome after long-term cyclosporine

S. Ito, K. Kaneko, Toshiaki Shimizu, 2010, Pediatric Nephrology.

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

S. Ito, K. Nozu, K. Iijima, 2009, Pediatric Nephrology.

An extremely mild clinical course in a case with LAMB2-associated nephritis diagnosed with next-generation sequencing

K. Nozu, K. Iijima, S. Fujinaga, 2021, CEN Case Reports.

Predictors of relapse and long-term outcome in children with steroid-dependent nephrotic syndrome after rituximab treatment

Toshiaki Shimizu, Shunsuke Sakurai, D. Hirano, 2017, Clinical and Experimental Nephrology.

Long-term remission of nephrotic syndrome with etanercept for concomitant juvenile idiopathic arthritis

S. Ito, S. Fujinaga, Tomonori Harada, 2010, Pediatric Nephrology.

Favorable outcome in children with idiopathic steroid-resistant nephrotic syndrome due to mesangial hypercellularity: A distinct disease entity?

S. Fujinaga, Yasuko Urushihara, 2016, Pediatric Nephrology.

Is the estimated glomerular filtration rate formula useful for evaluating the renal function of Down syndrome?

S. Endo, Yoshitaka Watanabe, S. Fujinaga, 2020, Pediatrics international : official journal of the Japan Pediatric Society.

Clinical characteristics of patients with early relapse during B-cell depletion after rituximab treatment for complicated steroid-dependent nephrotic syndrome

S. Endo, S. Fujinaga, Yuta Onuki, 2021, Clinical and Experimental Nephrology.

Relapsing peritonitis with Corynebacterium aquaticum in a boy receiving automated peritoneal dialysis

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2009, Pediatric Nephrology.

Prognostic factors of posterior urethral valves in children

H. Ida, M. Tada, D. Hirano, 2010 .

Renal rupture and urinary ascites with posterior urethral valves

H. Ida, D. Hirano, N. Nishizaki, 2010 .

Degree of foot process effacement in patients with genetic focal segmental glomerulosclerosis: a single-center analysis and review of the literature

M. Hattori, Y. Yamaguchi, S. Fujinaga, 2021, Scientific Reports.

Clinical course of asymptomatic nephrotic children without edema

S. Fujinaga, T. Nishino, Yusuke Gonda, 2018 .

Early identification of steroid dependency in Japanese children with steroid-sensitive nephrotic syndrome undergoing short-term initial steroid therapy

D. Hirano, N. Nishizaki, S. Fujinaga, 2011, Pediatric Nephrology.

Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy

K. Nakanishi, Takuhito Nagai, K. Iijima, 2015, Clinical and Experimental Nephrology.

Reference serum creatinine levels according to sex, age, and height in children with Down syndrome

S. Endo, Yoshitaka Watanabe, S. Fujinaga, 2021, European Journal of Pediatrics.

Mizoribine for renal sarcoidosis: effective steroid tapering and prevention of recurrence

S. Ito, Tomoko Nakamura, K. Nagahama, 2009, Pediatric Nephrology.

High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicity

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2005, Pediatric Nephrology.

Long-Term Outcome of SDNS Treated with High-Dose Mizoribine

S. Endo, D. Hirano, S. Fujinaga, 2022 .

Predictors of Treatment Response and Long-Term Outcomes in Young Children with Steroid-Dependent Nephrotic Syndrome Treated with High-Dose Mizoribine as First-Line Steroid-Sparing Agent.

S. Endo, D. Hirano, S. Fujinaga, 2022, The Tohoku journal of experimental medicine.

Synergistic protective effects of mizoribine and angiotensin II receptor blockade on cyclosporine A nephropathy in rats

Toshiaki Shimizu, A. Endo, S. Fujinaga, 2014, Pediatric Research.

Serum indoxyl sulfate as an early marker for detecting chronic cyclosporine nephrotoxicity

Toshiaki Shimizu, S. Fujinaga, Y. Ohtomo, 2010, Pediatrics international : official journal of the Japan Pediatric Society.

Acute renal failure due to obstructive uric acid stones associated with rotavirus gastroenteritis

K. Kaneko, Y. Yamashiro, M. Tada, 2005, Pediatric Nephrology.

Combined pharmacotherapy for nocturnal enuresis

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2001, Pediatric Nephrology.

Hypertensive encephalopathy in a boy with biopsy‐proven acute post‐streptococcal glomerulonephritis

Y. Yamashiro, S. Fujinaga, Y. Ohtomo, 2005, Pediatrics international : official journal of the Japan Pediatric Society.

Cyclosporine A for heavy proteinuria in a child with Henoch−Schönlein purpura nephritis

K. Kaneko, Y. Yamashiro, S. Fujinaga, 2004, Pediatrics international : official journal of the Japan Pediatric Society.

Transient pseudohypoaldosteronism complicating acute renal failure in an infant with vesico‐ureteral reflux and pyelonephritis

Toshiaki Shimizu, Y. Yamashiro, S. Fujinaga, 2009, Pediatrics international : official journal of the Japan Pediatric Society.

Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndrome

K. Kaneko, Y. Yamashiro, S. Fujinaga, 2006, Archives of Disease in Childhood.

Preprandial C2 monitoring of cyclosporine treatment in children with nephrotic syndrome

K. Kaneko, Y. Yamashiro, S. Akashi, 2005, Pediatric Nephrology.

Preventive Effect of Tonsillectomy on Recurrence of HSPN

S. Asanuma, D. Hirano, A. Endo, 2020 .

Preventive Effect of Tonsillectomy on Recurrence of Henoch-Schönlein Purpura Nephritis after Intravenous Methylprednisolone Pulse Therapy.

S. Asanuma, D. Hirano, A. Endo, 2020, The Tohoku journal of experimental medicine.

Re-treatment with high-dose prednisolone after rituximab infusion for childhood-onset steroid-resistant nephrotic syndrome

S. Fujinaga, Taichi Hara, 2014, Pediatric Nephrology.

Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome

S. Ito, K. Iijima, S. Fujinaga, 2013, Pediatric Nephrology.

The uncertainty of rituximab and steroid dosing in refractory steroid-resistant nephrotic syndrome.

D. Hirano, N. Nishizaki, S. Fujinaga, 2012, Clinical nephrology.

Unfavorable outcome in a child with megaureter‐megacystis syndrome complicated by mild acute poststreptococcal glomerulonephritis

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2010, Pediatrics international : official journal of the Japan Pediatric Society.

Mycoplasma pneumoniae-associated Henoch-Schönlein purpura nephritis.

K. Kaneko, Y. Yamashiro, S. Fujinaga, 1999, Pediatric nephrology.

Rapidly progressive acute post‐streptococcal glomerulonephritis in a child with IgA nephropathy

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2009, Pediatrics international : official journal of the Japan Pediatric Society.

Benign lymphoid polyposis : Two diffuse cases leading to fatal intestinal ischemia in children

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2009 .

Posterior reversible encephalopathy syndrome with exercise-induced acute kidney injury in renal hypouricemia type 1

Toshiaki Shimizu, S. Fujinaga, Y. Ohtomo, 2013, European Journal of Pediatrics.

Pulmonary edema in a boy with biopsy-proven poststreptococcal glomerulonephritis without urinary abnormalities

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2007, Pediatric Nephrology.

Impact of methylprednisolone pulse therapy on anthropometric outcomes in children with immunoglobulin A nephropathy and Henoch-Schönlein purpura nephritis.

S. Fujinaga, Y. Takemasa, 2022, Pediatrics International.

Outcome of children with heavy non-nephrotic proteinuria in Henoch–Schönlein nephritis

D. Hirano, A. Endo, S. Fujinaga, 2012, Pediatric Nephrology.

Plasma exchange combined with immunosuppressive treatment in a child with rapidly progressive IgA nephropathy

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2007, Pediatric Nephrology.

Single infusion of low-dose ofatumumab in a child with complicated nephrotic syndrome with anti-rituximab antibodies

S. Fujinaga, Koji Sakuraya, 2018, Pediatric Nephrology.

Hereditary renal hypouricemia: a cause of calcium oxalate urolithiasis in a young female.

K. Kaneko, Toshiaki Shimizu, K. Nozu, 2012, Clinical Nephrology.

Chronic cyclosporine-induced nephrotoxicity in children with steroid-resistant nephrotic syndrome

Toshiaki Shimizu, S. Fujinaga, 2013, Pediatric nephrology (Berlin, West).

Role of ultrasound in revealing complications following percutaneous renal biopsy in children.

H. Ida, D. Hirano, N. Nishizaki, 2013, Clinical Nephrology.

Recurrence of Henoch–Schoenlein purpura nephritis after long-term remission in a 15-year-old girl

K. Kaneko, Y. Yamashiro, S. Fujinaga, 2006, Pediatric Nephrology.

Unfavorable impact of anti-rituximab antibodies on clinical outcomes in children with complicated steroid-dependent nephrotic syndrome

S. Endo, Yoshitaka Watanabe, S. Fujinaga, 2020, Pediatric nephrology (Berlin, West).

Is cytokine-release syndrome the cause of rituximab treatment-related infusion reactions in children with nephrotic syndrome? Impact of anti-rituximab antibodies

S. Fujinaga, T. Nishino, 2018, Pediatric Nephrology.

Gradual tapering of desmopressin leads to better outcome in nocturnal enuresis

Toshiaki Shimizu, S. Fujinaga, Y. Ohtomo, 2015, Pediatrics International.

Efficacy of the novel selective β3-adrenoreceptor agonist vibegron for treatment-resistant monosymptomatic nocturnal enuresis in children.

Yoshitaka Watanabe, S. Fujinaga, Mayu Nakagawa, 2020, International journal of urology : official journal of the Japanese Urological Association.

Can cranberry juice be a substitute for cefaclor prophylaxis in children with vesicoureteral reflux?

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2009, Pediatrics international : official journal of the Japan Pediatric Society.

Nephrotoxicity of once-daily cyclosporine A in minimal change nephrotic syndrome

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2012, Pediatric Nephrology.

Acute kidney injury due to rotavirus gastroenteritis-associated obstructive uric acid stones in a Japanese infant harboring a heterozygous W258X mutation

S. Fujinaga, T. Nishino, 2016, Pediatric Nephrology.

Mycophenolate mofetil therapy for childhood-onset steroid dependent nephrotic syndrome after long-term cyclosporine: extended experience in a single center.

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2009, Clinical nephrology.

Cyclosporine versus mycophenolate mofetil for maintenance of remission of steroid-dependent nephrotic syndrome after a single infusion of rituximab

K. Kaneko, Toshiaki Shimizu, S. Fujinaga, 2013, European Journal of Pediatrics.

Inhibitory effect of steroid on absorption fever after percutaneous renal biopsy

S. Fujinaga, Koji Sakuraya, 2019, Pediatrics international : official journal of the Japan Pediatric Society.

Clinical, Pathological, and Genetic Characteristics in Patients with Focal Segmental Glomerulosclerosis

S. Ito, K. Matsuoka, N. Yoshikawa, 2022, Kidney360.

Single daily high-dose mizoribine therapy for children with steroid-dependent nephrotic syndrome prior to cyclosporine administration

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2011, Pediatric Nephrology.

Definition of low nocturnal bladder capacity in Japanese enuretic children

S. Fujinaga, Mayu Nakagawa, 2021, Pediatrics international : official journal of the Japan Pediatric Society.

Initial combination therapy with desmopressin, solifenacin, and alarm for monosymptomatic nocturnal enuresis

N. Nishizaki, S. Fujinaga, Y. Ohtomo, 2017, Pediatrics international : official journal of the Japan Pediatric Society.

Impact of interrupted cyclosporine treatment on the development of chronic nephrotoxicity in children with steroid-dependent nephrotic syndrome

S. Fujinaga, Yasuko Urushihara, 2017, Pediatric Nephrology.

Positive role of rituximab in switching from cyclosporine to mycophenolate mofetil for children with high-dose steroid-dependent nephrotic syndrome

Toshiaki Shimizu, S. Fujinaga, Y. Ohtomo, 2015, Pediatric Nephrology.

Anti-B cell strategy for complicated steroid-dependent nephrotic syndrome in children with antirituximab antibodies

S. Endo, S. Fujinaga, 2022, Pediatric Nephrology.

Risk factor for persistent proteinuria in adulthood after clinical remission in Japanese children with immunoglobulin A nephropathy: impact of tonsillectomy combined with intravenous pulse methylprednisolone

S. Fujinaga, Chisato Umeda, 2020, Clinical and Experimental Nephrology.

Detection of Splicing Abnormalities and Genotype-Phenotype Correlation in X-linked Alport Syndrome.

M. Matsuo, K. Nakanishi, M. Kawano, 2018, Journal of the American Society of Nephrology : JASN.

Impact of acute kidney injury at the onset of idiopathic nephrotic syndrome in Japanese children

S. Fujinaga, Kanako Kusaba, 2019, Clinical and Experimental Nephrology.

Rituximab treatment for steroid-resistant nephrotic syndrome

Toshiaki Shimizu, D. Hirano, A. Endo, 2011 .

Thrombotic thrombocytopenic purpura as initial presentation of systemic lupus erythematosus.

S. Endo, S. Fujinaga, Y. Takemasa, 2022, Pediatrics international : official journal of the Japan Pediatric Society.

Spontaneous femoral artery thrombosis in childhood‐onset nephrotic syndrome

S. Fujinaga, Koji Sakuraya, 2019, Pediatrics international : official journal of the Japan Pediatric Society.

Protective Effects of Mizoribine on Cyclosporine A Nephropathy in Rats

Toshiaki Shimizu, S. Fujinaga, Y. Ohtomo, 2009, Pediatric Research.

Nephronophthisis Cannot Be Detected by Urinary Screening Program

M. Hattori, Y. Yamaguchi, H. Ida, 2013, Clinical pediatrics.

Two dosing regimens for steroid therapy in nephrotic syndrome

D. Hirano, S. Fujinaga, 2014, Pediatric Nephrology.

Is single-daily low-dose cyclosporine therapy really effective in children with idiopathic frequent-relapsing nephrotic syndrome?

K. Kaneko, Y. Yamashiro, S. Fujinaga, 2008, Clinical nephrology.

A different clinical manifestation in a Japanese family with autosomal dominant distal renal tubular acidosis caused by SLC4A1 mutation

K. Nozu, K. Iijima, S. Fujinaga, 2020, CEN Case Reports.

Maintenance therapy with mycophenolate mofetil for children with severe lupus nephritis after low-dose intravenous cyclophosphamide regimen

K. Kaneko, Toshiaki Shimizu, S. Fujinaga, 2008, Pediatric Nephrology.

Seminal vesicle abscesses associated with ipsilateral multicystic dysplastic kidney in an infant

Toshiaki Shimizu, M. Tada, Y. Kitano, 2008, Pediatric Nephrology.

Favorable renal outcome in Japanese children with ANCA-associated pauci-immune glomerulonephritis: impact of urine screening program

S. Fujinaga, T. Nishino, 2017, Pediatric Nephrology.

Medical and psychosocial outcomes in adolescents and young adults with childhood-onset end-stage kidney disease: a multicenter study in Japan

I. Narita, M. Hattori, M. Iwano, 2023, Clinical and Experimental Nephrology.

A multicenter retrospective study of calcineurin inhibitors in nephrotic syndrome secondary to podocyte gene variants.

L. Weber, M. Tkaczyk, L. Prikhodina, 2023, Kidney international.

Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.

Toshiaki Shimizu, S. Fujinaga, Koji Sakuraya, 2016, Clinical Nephrology.

Characterization of contiguous gene deletions in COL4A6 and COL4A5 in Alport syndrome-diffuse leiomyomatosis

I. Vořechovský, K. Nakanishi, M. Yanagita, 2017, Journal of Human Genetics.

Should rituximab be administered before cyclophosphamide as a first-line steroid-sparing agent to young children with steroid-dependent nephrotic syndrome?

S. Fujinaga, Akira Mizutani, 2020, Clinical and Experimental Nephrology.

Profound effect of post-rituximab mycophenolate mofetil administration for persistent hypogammaglobulinemia in young children with steroid-dependent nephrotic syndrome

S. Fujinaga, Yuji Tomii, 2020, Clinical and Experimental Nephrology.

Risk factors for early B cell recovery following single-dose rituximab therapy in Japanese children with steroid-dependent nephrotic syndrome

S. Fujinaga, T. Nishino, 2018, Pediatric Nephrology.

Repeated administrations of rituximab along with steroids and immunosuppressive agents in refractory steroid-resistant nephrotic syndrome

S. Fujinaga, Koji Sakuraya, 2017, Indian Pediatrics.

Hypogammaglobulinemia and infection after administration of rituximab for steroid-dependent nephrotic syndrome

Yoshitaka Watanabe, S. Fujinaga, T. Nishino, 2020, Japanese journal of pediatric nephrology.

Membranoproliferative glomerulonephritis Type 3 associated with Kabuki syndrome.

K. Kaneko, Toshiaki Shimizu, D. Hirano, 2014, Clinical nephrology.

Increased urinary angiotensinogen is an effective marker of chronic renal impairment in very low birth weight children

K. Kaneko, Toshiaki Shimizu, S. Nagata, 2014, Clinical and Experimental Nephrology.

Predictive factors of long-term disease remission after rituximab administration in patients with childhood-onset complicated steroid-dependent nephrotic syndrome: a single-center retrospective study

D. Hirano, S. Fujinaga, Koji Sakuraya, 2023, Clinical and Experimental Nephrology.

Single dose of rituximab for refractory steroid-dependent nephrotic syndrome in children

S. Ito, K. Nozu, K. Iijima, 2009, Pediatric Nephrology.

Effects of Human Milk and Spermine on Hydrogen Peroxide-Induced Oxidative Damage in IEC-6 Cells

K. Kaneko, Toshiaki Shimizu, Y. Yamashiro, 2005, Journal of pediatric gastroenterology and nutrition.

Efficacy of rituximab and risk factors for poor prognosis in patients with childhood-onset steroid-resistant nephrotic syndrome: a multicenter study.

S. Fujinaga, K. Kamei, M. Ogura, 2024, Pediatric nephrology.

A 3-year-old boy with steroid-resistant nephrotic syndrome who was diagnosed with severe lupus nephritis one year later: a case report

S. Fujinaga, H. Murakami, Y. Takemasa, 2022, Japanese journal of pediatric nephrology.

Two different clinical aspects of Japanese children with asymptomatic nephrotic syndrome at onset

S. Fujinaga, Yusuke Gonda, 2019, Clinical and Experimental Nephrology.